- Summary
- Actions
- Committee Votes
- Floor Votes
- Memo
- Text
- LFIN
- Chamber Video/Transcript
S08038 Summary:
| BILL NO | S08038 |
| SAME AS | SAME AS A08501 |
| SPONSOR | BRESLIN |
| COSPNSR | |
| MLTSPNSR | |
| Rpld §4902 sub§ (a) ¶14, §4903 sub§ (e-1), amd §§4902 & 4903, Ins L; rpld §4902 sub 1 ¶(1), §4903 sub 5-a, amd §§4902 & 4903, Pub Health L (as proposed in S.2677-A & A.463-A) | |
| Requires written notice of an adverse determination made by a utilization review agent in relation to a step therapy protocol override determination which includes the clinical review criteria relied upon to make such determination and any applicable alternative prescription drugs subject to the step therapy protocol of the utilization review agent. | |